XML 51 R40.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2023
Equity [Abstract]  
Summary of Stock Option Activity Stock option activity for the three months ended March 31, 2023 is presented below:
Outstanding optionsWeighted average exercise priceWeighted average remaining contractual term (years)Aggregate intrinsic value (thousands)
Balance as of December 31, 202212,558,158 $12.30 6.4$93 
Granted237,642 8.72 
Exercised(77,378)5.99 
Canceled(28,419)11.48 
Balance as of March 31, 202312,690,003 12.27 6.23,554 
Vested and exercisable as of March 31, 20239,631,022 12.04 5.53,169 
Vested and expected to vest as of March 31, 202312,529,364 12.26 6.23,524 
Summary of Restricted Stock Activity , for the three months ended March 31, 2023 is presented below:
Outstanding RSUs, RSAs and PSUsWeighted-average grant date fair value per shareWeighted average remaining contractual term (years)Aggregate intrinsic value (thousands)
Balance as of December 31, 202210,764,197 $11.46 1.7$63,059 
Awarded1,649,472 8.42
Released(590,994)15.56
Canceled(902,679)12.40
Balance as of March 31, 202310,919,996 10.701.793,694
Vested and expected to vest as of March 31, 20239,595,276 10.751.682,327
Summary of Stock-Based Compensation Expense Stock-based compensation expense recognized in connection with stock options, RSUs, RSAs, PSUs and the Employee Stock Purchase Plan (ESPP) during each of the three months ended March 31, 2023 and 2022 were as follows (in thousands):

Three Months Ended March 31,

20232022
Cost of net revenue$197 $240 
Product development4,324 4,133 
Sales, marketing and support2,228 1,787 
General and administrative5,345 6,676 
      Total$12,094 $12,836